A patient with lung adenocarcinoma and RET fusion treated with vandetanib

J Thorac Oncol. 2013 May;8(5):e43-4. doi: 10.1097/JTO.0b013e31828a4d07.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / genetics*
  • Adenocarcinoma / secondary
  • Adenocarcinoma / therapy*
  • Antineoplastic Agents / therapeutic use*
  • Humans
  • Lung Neoplasms / genetics*
  • Lung Neoplasms / pathology
  • Lung Neoplasms / therapy*
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Multimodal Imaging
  • Oncogene Proteins, Fusion / genetics
  • Piperidines / therapeutic use*
  • Protein Kinase Inhibitors / therapeutic use*
  • Quinazolines / therapeutic use*

Substances

  • Antineoplastic Agents
  • KIF5B-RET fusion protein, human
  • Oncogene Proteins, Fusion
  • Piperidines
  • Protein Kinase Inhibitors
  • Quinazolines
  • N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine